Queue is making use of automation to enhance prescription achievement. Supply: Queue
Queue right now emerged from stealth with an autonomous pharmacy system and $12.6 million in seed funding. The corporate mentioned its system is designed to make prescription achievement quicker, extra accessible, and cost-effective whereas supporting rigorous security and verification protocols.
“Pharmacy in America is structurally damaged,” said Josh Liu, co-founder and chief know-how officer of Queue. “Queue is a whole reimagining of how drugs get disbursed, verified, and delivered. We constructed the machine the business has wanted for many years, and the demand we’re seeing proves it.”
Pharmacies are dealing with “overwhelming workloads and job dissatisfaction,” according to Drugstore Information. Faculties are graduating 3,000 to 4,000 fewer pharmacists than can be wanted over the following 5 to 6 years, it mentioned.
Pharmacy technician vacancies have been reported at 40% or greater, reported the American Society of Well being-System Pharmacists. As one pharmacist noted, worker shortages can enhance the danger of human error.
As well as, pharmacies are dropping cash on a rising share of prescriptions due to “negative reimbursements,” which put the business beneath much more strain. Researchers at USC and UC Berkeley discovered that almost one in three pharmacies has closed since 2010, resulting in “pharmacy deserts.” Due to these structural forces, the $670.6 billion U.S. retail pharmacy market has few viable paths ahead.
Queue develops system to ease prescription achievement
Queue was co-founded by Nick Desai, CEO, a six-time venture-backed entrepreneur who beforehand based and led Heal, a house healthcare firm that raised greater than $200 million, and Liu, whose expertise spans Tesla and Zipline.
“We predict that robotics and AI ought to be utilized in a means that really allows better human flourishing,” Liu instructed The Robotic Report. “In our specific case, that may imply enabling extra reference to folks and enabling higher service and well being outcomes for most people.”
Palo Alto, Calif.-based Queue mentioned its robotic system fills and verifies prescriptions from sealed wholesale tablet bottles with out requiring an on-site pharmacist. It mentioned this can allow lower-cost prescription achievement and broader pharmacy entry throughout retail, healthcare, and different settings.
Every cell within the system can maintain 1000’s of drugs, and it could possibly fill a vial of 60 drugs each 30 seconds, defined Liu. Queue has developed software program for safety and ease of use, initially by pharmacists and ultimately straight by clients.
The platform presently helps 280 of essentially the most prescribed drugs within the U.S., the corporate claimed.
“The accuracy of the medication we dispense needs to be 100% finish to finish,” acknowledged Liu. “We take into consideration the issue from the second the drug is made to when it’s imported into the states, put into our machine, after which on the surface coming in with the completed vial crammed along with your pharmaceuticals. The complete chain of custody that helps security is basically important for us.”
Queue mentioned it could possibly ship drugs at as much as 96% decrease value than conventional pharmacy operations, and it may be deployed throughout rural communities and different care settings the place pharmacy entry is constrained. The corporate mentioned it’s positioning autonomous prescription achievement as “a brand new infrastructure layer for American healthcare, enabling pharmacy companies to maneuver nearer to sufferers whereas delivering dramatically higher economics.”
Queue mentioned it has already secured a significant nationwide pharmacy chain as a buyer and deployed a working prototype to get early industrial validation in a market dealing with pressing labor, value, and entry challenges.
“We consider the true check comes from the sector, not within the lab,” Liu mentioned. “We’re excited to get the machines out in the true world, fulfilling actual pharmaceuticals for folk, and studying from that course of. The following yr is basically about scaling.”
AlleyCorp leads seed spherical
Queue closed an oversubscribed $12.6 million spherical led by AlleyCorp, following a $6 million pre-seed spherical led by Riot Ventures lower than a yr in the past, bringing Queue’s complete funding to $18.6 million. Extra buyers embrace House Capital, Ubiquity Ventures, Grep Ventures, and Banter Capital.
“What the Queue workforce has achieved is uncommon within the improvement of {hardware} for healthcare,” mentioned Abe Murray, basic accomplice at AlleyCorp. “We consider Queue is constructing important infrastructure that may each enhance accessibility for sufferers to get the prescriptions they want, whereas utilizing robotics and automation to enormously enhance labor constraints that exist throughout pharmacies.”
“Pharmacy has an infrastructure downside. Whereas the business has been pressured to work round labor shortages, retailer closures, and damaged unit economics, Nick and Josh have taken a basically totally different strategy: automating the bodily achievement layer itself,” added Will Coffield, a accomplice at Riot Ventures. “Queue is precisely the form of firm Riot backs early. It has distinctive founders fixing a large, pressing downside with know-how that may ship outsized affect.”
Queue mentioned it’s going to use the funding to speed up product improvement, broaden deployments with enterprise pharmacy clients, and develop its engineering workforce. The company presently has a workforce of 20 engineers in Silicon Valley with expertise from Rivian, Waymo, and aerospace corporations, and it’s actively hiring throughout robotics, {hardware}, software program, and pharmacy operations.
“It’s extra than simply the capital; it’s actually about each the relationships we’re constructing and the shared imaginative and prescient of how we are able to convey this future to actuality a lot quicker,” mentioned Liu. “Individuals consider pharmacies as not essentially the flashiest, sexiest factor, however I believe what attracts each our expertise in addition to the parents who’ve invested in us is that they see it extra as a systemic concern. It’s one which, fairly frankly, our nation hasn’t resolved, and it’s solely getting worse. So we’re actually hitting on one thing fairly foundational that’s going to be impactful for a lot of, a few years.”
Submit your session concept for the 2026 RoboBusinessThe put up Queue raises funding to construct absolutely autonomous pharmacy appeared first on The Robotic Report.
